XERS EPS Estimates
Xeris Biopharma Holdings, Inc.
$16.52
+$0.69(+4.36%)
69
Overall
40
Value
100
Tech
68
Quality
Market Cap
$3.02B
Volume
3.79M
52W Range
$5.25 - $15.21
Target Price
$14.00
XERS EPS estimates: the consensus estimate for Xeris Biopharma Holdings, Inc.'s current fiscal year is $0.07 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
XERS EPS Estimates
- EPS estimate, current quarter
- $0.03
- EPS estimate, next quarter
- $0.03
- EPS estimate, current year
- $0.07
- EPS estimate, next year
- $0.30
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2023 | $-0.45 |
| 2023 | $-0.12 |
| 2022 | $-0.70 |
| 2021 | $-1.55 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XERS | $16.52 | +4.4% | 3.79M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Xeris Biopharma Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW